Breast cancer claimed over 670,000 lives worldwide in 2022, 11,000 of those were Filipinos.
Student-made tool could improve early breast cancer detection
UP scientists develop mathematical model for detecting early signs of metastasis
By MB Lifestyle
At A Glance
- LVI is when cancer cells begin invading lymphatic and blood vessels, allowing it to spread throughout the body in a process known as metastasis.
A CLOSER LOOK Biologist Regina Joyce Ferrer analyzing breast cancer organoids. (Photo: Dr. Michael Velarde)
Second only to lung cancer, breast cancer is one of the leading cause of cancer-related mortality in the country. A new tool developed by biologists from the University of the Philippines (UP) hopes to help in detecting early symptoms.
“If we can detect lymphovascular invasion (LVI) earlier, doctors could personalize patient treatment and improve their outcomes,” shares Dr. Michael Velarde from UP Diliman College of Science Institute of Biology (UPD-CS IB). “This could help avoid ineffective treatments and focus on strategies that work better for aggressive breast cancer.”
LVI is when cancer cells begin invading lymphatic and blood vessels, allowing it to spread throughout the body in a process known as metastasis. In order to detect LVI, tissue surrounding a tumor needs to be surgically removed. This new tool under development hopes to remove the need for that.
Using the clinical data of over 625 breast cancer patients at the Philippine General Hospital and publicly available data, Dr. Velarde and his team (Allen Joy Corachea, Regina Joyce Ferrer, Lance Patrick Ty, and Madeleine Morta of UPD-CS IB, and researchers from the Philippine Genome Center and UP Manila) managed to find certain genes that survive chemotherapy and eventually metastasize. From this, the team was able to develop a regression model that analyzed the expression patterns of the two genes. Their model managed to correctly predict LVI status at the time of biopsy and before surgery 92 percent of the time.
Though the tool is still in its early stages of development, there are hopes it can make detecting early signs of breast cancer and providing the necessary treatment much easier. “More validation studies are needed before this can be used in clinics,” mentions Dr. Velarde. “Our goal is to develop a practical test that can be used in Philippine hospitals to guide doctors in choosing the best treatment for each patient.”